<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">31823953</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">0975-5764</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>18</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <MedlineDate>2019 Oct-Dec</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of African medicine</Title>
                <ISOAbbreviation>Ann Afr Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria.</ArticleTitle>
            <Pagination>
                <MedlinePgn>191-195</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4103/aam.aam_18_19</ELocationID>
            <Abstract>
                <AbstractText Label="Introduction">Mineral and bone disorders (MBD) are among the important complications of chronic kidney disease (CKD) including end-stage renal disease. In addition to the higher rate of all-cause and cardiovascular-related mortality, MBD is also a cause of significant morbidity in CKD patients.</AbstractText>
                <AbstractText Label="Materials and Methods">This is a cross-sectional study of all consenting patients on hemodialysis at Aminu Kano Teaching Hospital, between December 2011 and June 2012. With the aid of an interviewer-administered questionnaire, the demographic profile and clinical features of the patients were obtained. After a general physical examination, blood sample was taken for the determination of calcium, phosphate, intact parathyroid hormone, 25 hydroxy (25[OH]) Vitamin D<sub>3</sub>, packed cell volume, serum creatinine, and potassium.</AbstractText>
                <AbstractText Label="Results">Forty-eight patients on maintenance hemodialysis were recruited for the study, 39 (81.3%) were male and 9 (18.8%) were female. The age range was 40-59 years, with a mean of 45.96 Â± 13.7 years. Chronic glomerulonephritis was the predominant cause of CKD (25%). Hyperphosphatemia was noted in 19 (39.5%) of the patients, whereas 22 (46%) had hypocalcemia. In 26 (54.1%) of the patients, the calcium-phosphate product was &gt;4.55 mmol<sup>2</sup>/L<sup>2</sup>. We found that 58% of the patients had CKD-MBD, of which 15 (31%) had secondary hyperparathyroidism, whereas 13 (27%) had features suggestive of adynamic bone disease. None of the patient had normal serum 25(OH) Vitamin D<sub>3</sub>(mean: 43.79 Â± 21 ng/ml).</AbstractText>
                <AbstractText Label="Conclusion">CKD-MBD is common among patients on hemodialysis in our center. Screening for CKD-MBD and appropriate use of phosphate binder and Vitamin D when indicated are highly recommended.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Abdu</LastName>
                    <ForeName>Alhaji</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abdu</LastName>
                    <ForeName>Aliyu</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arogundade</LastName>
                    <ForeName>Fatiu A</ForeName>
                    <Initials>FA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Obafemi Awolowo University Teaching Hospital Complex, Ile Ife, Osun, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>Ann Afr Med</MedlineTA>
            <NlmUniqueID>101231417</NlmUniqueID>
            <ISSNLinking>0975-5764</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012080" MajorTopicYN="N">Chronic Kidney Disease-Mineral and Bone Disorder</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="fre">
            <AbstractText><b>RÃ©sumÃ©</b><b>Introduction:</b> Les maladies minÃ©rales et osseuses comptent parmi les complications importantes de la nÃ©phropathie chronique, notamment: phase terminale de la maladie rÃ©nale. Outre le taux plus Ã©levÃ© de mortalitÃ© toutes causes confondues et liÃ©e Ã  la cardiopathie, la MBD est Ã©galement une cause de morbiditÃ© chez les patients atteints d'IRC. <b>MatÃ©riels et MÃ©thodes:</b> Ceci est une Ã©tude transversale de tous les patients consentants sous hÃ©modialyse Ã  Aminu HÃ´pital universitaire de Kano, entre dÃ©cembre 2011 et juin 2012. Ã l'aide d'un questionnaire administrÃ© par un intervieweur, le le profil et les caractÃ©ristiques cliniques des patients ont Ã©tÃ© obtenus. AprÃ¨s un examen physique gÃ©nÃ©ral, un Ã©chantillon de sang a Ã©tÃ© prÃ©levÃ© pour la determination de calcium, de phosphate, d'hormone parathyroÃ¯de intacte, de 25 hydroxy (25 [OH]) vitamine D3, de volume de globules rouges, de crÃ©atinine sÃ©rique et de potassium. <b>RÃ©sultats:</b> Quarante-huit patients sous hÃ©modialyse d'entretien ont Ã©tÃ© recrutÃ©s pour l'Ã©tude, 39 (81,3%) Ã©taient des hommes et 9 (18,8%) des femmes. La tranche d'Ã¢ge Ã©tait comprise entre 40 et 59 ans, avec une moyenne de 45,96 Â± 13,7 ans. La glomÃ©rulonÃ©phrite chronique Ã©tait la principale cause de nÃ©phropathie chronique (25%). Une hyperphosphatÃ©mie a Ã©tÃ© notÃ©e chez 19 (39,5%) des patients, alors que 22 (46%) prÃ©sentaient une hypocalcÃ©mie. Dans 26 (54,1%) des patients, le le produit de phosphate de calcium Ã©tait&gt; 4,55 mmol2 / L2. Nous avons constatÃ© que 58% des patients Ã©taient atteints de MRC, dont 15 (31%) avaient une atteinte secondaire. hyperparathyroÃ¯die, alors que 13 (27%) prÃ©sentaient des signes Ã©vocateurs d'une maladie osseuse adynamique. Aucun patient ne prÃ©sentait un taux sÃ©rique normal de 25 (OH) Vitamine D3 (moyenne: 43,79 Â± 21 ng / ml). <b>Conclusion:</b> La MPC est frÃ©quente chez les patients hÃ©modialysÃ©s de notre centre. DÃ©pistage de CKD-MBD et l'utilisation appropriÃ©e du liant de phosphate et de la vitamine D lorsque cela est indiquÃ© sont fortement recommandÃ©s.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Biochemical markers</Keyword>
            <Keyword MajorTopicYN="Y">Northwest Nigeria</Keyword>
            <Keyword MajorTopicYN="Y">chronic kidney disease-mineral bone disorders</Keyword>
            <Keyword MajorTopicYN="Y">maintenance hemodialysis</Keyword>
        </KeywordList>
        <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31823953</ArticleId>
            <ArticleId IdType="pii">AnnAfrMed_2019_18_4_191_272400</ArticleId>
            <ArticleId IdType="doi">10.4103/aam.aam_18_19</ArticleId>
            <ArticleId IdType="pmc">PMC6918790</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Kidney Dis. 1995 Oct;26(4):622-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7573017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Afr Health Sci. 2015 Sep;15(3):941-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26957985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Nephrol Renovasc Dis. 2013;6:1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23319870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>West Afr J Med. 2010 Mar-Apr;29(2):75-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20544630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Paediatr. 2000 Jun;89(6):666-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10914959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2008 Sep;52(3):519-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18514987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2000 Feb;11(2):330-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10665940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2008 Sep;52(3):531-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18657891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Afr J Med Med Sci. 2002 Dec;31(4):311-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15027769</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Saudi J Kidney Dis Transpl. 2006 Sep;17(3):401-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16970264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrology (Carlton). 2003 Oct;8(5):261-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15012715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int Suppl (2011). 2017 Jul;7(1):1-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30675420</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2003 Aug;64(2):737-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 2001 Aug;86(8):3801-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11502814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2011 Jun;26(6):1948-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20466670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrourol Mon. 2012 Fall;4(4):613-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23573501</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2003 Dec;14(12):3270-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14638926</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Nephrol. 2014 Sep;24(5):302-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25249720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2001 Jul;16(7):1518-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11427663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 1996;11 Suppl 3:111-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8840325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2002 Feb 20;39(4):695-701</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11849871</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>